differences between semaglutide and tirzepatide vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Understand the Difference between Semaglutide

Novo Nordisk has a head start, but competition is coming

GLP-1 receptor agonists bind to GLP-1 receptors in the pancreas, stimulating insulin secretion in a glucose-dependent manner whilst suppressing glucagon release

Novo Nordisk's patent for Saxenda expires later this year, and rivals Teva, Pfizer and Mylan are all expected to launch generic versions of liraglutide later in 2024

It reduces appetite, slows gastric emptying, and uniquely among GLP-1s activates glucagon signaling which directly promotes fat oxidation in the liver

Financial commitment Running both compounds simultaneously involves significant ongoing expense

No Video Calls Required 100% online care through text and email to fit your schedule